ProMIS Neurosciences Stock Surges on Unprecedented Growth Catalysts
ProMIS Neurosciences Inc. (NASDAQ: PMN) witnessed a significant surge in its share value on Monday, following a compelling presentation of preclinical data at AAIC 2023. The data showcased the promising therapeutic potential of their leading candidate, PMN310, for Alzheimer’s disease (AD), along with groundbreaking research on a computationally-derived AD vaccine. The findings revealed that PMN310…